摘要:
A method of cancer diagnosis characterized in that ROBO1 protein is detected. Further, there is disclosed a method of treating diseases attributed to abnormal cell growth, comprising administering an antibody capable of binding to ROBO1, and are disclosed, comprising an antibody capable of binding to ROBO1 as an active ingredient, a pharmaceutical composition, cytostatic agent and anticancer agent. Still further, there is disclosed a method of inhibiting the growth of ROBO1 expression cells or method of inducing cytotoxicity in ROBO1 expression cells, comprising bringing an antibody capable of binding to ROBO1 into contact with ROBO1 expression cells. Moreover, there is disclosed a method of monitoring the intensification of hepatitis severity, comprising detection of ROBO1 protein.
摘要:
A protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOS:1 to 65 or its fragment; an antibody recognizing the same or an antigen-binding fragment thereof; and a polynucleotide having a nucleotide sequence comprising at least 12 consecutive nucleotides in any of the nucleotide sequences represented by SEQ ID NOS:1 to 65 or a nucleotide sequence complementary thereto: The above gene and protein are useful as diagnostics and remedies for cancer.
摘要:
A bile duct cancer cell proliferation inhibitor containing antiglypican 3 antibody as the active ingredient. It is preferable that the antiglypican 3 antibody has a cytotoxic activity such as antibody-dependent cellular cytotoxicity (ADCC) activity or complement-dependent cytotoxicity (CDC) activity. A diagnostic for bile duct cancer containing antiglypican 3 antibody.
摘要:
It is intended to provide a cell proliferation inhibitor and a cell proliferation inhibitor which is usable in treating diseases based on abnormal proliferation of cells, in particular, cancer. Cell proliferation inhibitors containing anti-glypican 3 antibody as the active ingredient.
摘要:
It is intended to provide a method of predicting the recurrence after treating liver cancer. A method of predicting the recurrence after treating liver cancer characterized by assaying GPC3 in a test sample with the use of anti-GPC3 antibody.
摘要:
Disclosed is a novel diagnosis or therapeutic method for pancreatic cancer using a blood marker. Specifically, disclosed is a diagnostic or therapeutic agent for pancreatic cancer, which comprises an anti-AMIGO2 antibody.
摘要:
A document information processing system includes: a dictionary (16) for storing a verb indicating a plurality of element names and an interaction between the element names; a document database (14) for storing a plurality of document information; input means (12) for inputting the element names; and a data control unit (10) for referencing the dictionary and the document database for each of the element names inputted, extracting a multinomial relationship, extracting an overlapped portion of the multinomial relationship extracted for each of the elements, and plotting a pass way map while assuming the overlapped portion as one information.